Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Peter R. Carroll; J. Kellogg Parsons; Gerald Andriole; Robert R. Bahnson; Daniel A. Barocas; William J. Catalona; Douglas M. Dahl; John W. Davis; Jonathan I. Epstein; Ruth B. Etzioni; Veda N. Giri; George P. Hemstreet; Mark H. Kawachi; Paul H. Lange; Kevin R. Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M. Morgan; Robert B. Nadler; Michael Poch; Chuck Scales; Terrence M. Shanefelt; Andrew J. Vickers; Robert Wake; Dorothy A. Shead; Maria Ho

doi:10.6004/jnccn.2014.0120

Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Veda N. Giri, George P. Hemstreet, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Robert B. NadlerMichael Poch, Chuck Scales, Terrence M. Shanefelt, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Maria Ho

Research output: Contribution to journal › Article › peer-review

76 Scopus citations

Abstract

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

Original language	English (US)
Pages (from-to)	1211-1219
Number of pages	9
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	12
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2014.0120
State	Published - Sep 1 2014
Externally published	Yes

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2014.0120

Cite this

Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Barocas, D. A., Catalona, W. J., Dahl, D. M., Davis, J. W., Epstein, J. I., Etzioni, R. B., Giri, V. N., Hemstreet, G. P., Kawachi, M. H., Lange, P. H., Loughlin, K. R., Lowrance, W., Maroni, P., Mohler, J., Morgan, T. M., ... Ho, M. (2014). Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 12(9), 1211-1219. https://doi.org/10.6004/jnccn.2014.0120

Carroll, PR, Parsons, JK, Andriole, G, Bahnson, RR, Barocas, DA, Catalona, WJ, Dahl, DM, Davis, JW, Epstein, JI, Etzioni, RB, Giri, VN, Hemstreet, GP, Kawachi, MH, Lange, PH, Loughlin, KR, Lowrance, W, Maroni, P, Mohler, J, Morgan, TM, Nadler, RB, Poch, M, Scales, C, Shanefelt, TM, Vickers, AJ, Wake, R, Shead, DA & Ho, M 2014, 'Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 12, no. 9, pp. 1211-1219. https://doi.org/10.6004/jnccn.2014.0120

@article{a866fb1885df42c992392add2eb67482,

title = "Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.",

author = "Carroll, {Peter R.} and Parsons, {J. Kellogg} and Gerald Andriole and Bahnson, {Robert R.} and Barocas, {Daniel A.} and Catalona, {William J.} and Dahl, {Douglas M.} and Davis, {John W.} and Epstein, {Jonathan I.} and Etzioni, {Ruth B.} and Giri, {Veda N.} and Hemstreet, {George P.} and Kawachi, {Mark H.} and Lange, {Paul H.} and Loughlin, {Kevin R.} and William Lowrance and Paul Maroni and James Mohler and Morgan, {Todd M.} and Nadler, {Robert B.} and Michael Poch and Chuck Scales and Shanefelt, {Terrence M.} and Vickers, {Andrew J.} and Robert Wake and Shead, {Dorothy A.} and Maria Ho",

year = "2014",

month = sep,

day = "1",

doi = "10.6004/jnccn.2014.0120",

language = "English (US)",

volume = "12",

pages = "1211--1219",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "9",

}

TY - JOUR

T1 - Prostate cancer early detection, version 1.2014

T2 - Featured updates to the NCCN guidelines

AU - Carroll, Peter R.

AU - Parsons, J. Kellogg

AU - Andriole, Gerald

AU - Bahnson, Robert R.

AU - Barocas, Daniel A.

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Davis, John W.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Giri, Veda N.

AU - Hemstreet, George P.

AU - Kawachi, Mark H.

AU - Lange, Paul H.

AU - Loughlin, Kevin R.

AU - Lowrance, William

AU - Maroni, Paul

AU - Mohler, James

AU - Morgan, Todd M.

AU - Nadler, Robert B.

AU - Poch, Michael

AU - Scales, Chuck

AU - Shanefelt, Terrence M.

AU - Vickers, Andrew J.

AU - Wake, Robert

AU - Shead, Dorothy A.

AU - Ho, Maria

PY - 2014/9/1

Y1 - 2014/9/1

N2 - The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

AB - The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

UR - http://www.scopus.com/inward/record.url?scp=84907288188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907288188&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0120

DO - 10.6004/jnccn.2014.0120

M3 - Article

C2 - 25190691

AN - SCOPUS:84907288188

SN - 1540-1405

VL - 12

SP - 1211

EP - 1219

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Prostate cancer early detection, version 1.2014: Featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this